Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870; TTY/TDD Users 1-800-735-2258 - [E-mail Us] DOCKETS ENTERED on October 25, 2002 TABLE OF CONTENTS Hyper links are part of the Docket title - not all dockets/documents are linked NOTE: Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence. |
|
77N-0094 OTC Internal Analgesic, Antipyretic & Antirheumatic Products
EXT 11 Albemarle Corp. Vol#: 235
84F-0331 WHITE MINERAL OIL AS DEFOAMING AGENT IN BEER
NWL 1 Quest International Vol#: 1
98N-0337 Over the counter human drugs labeling requirements
APP 43 GlaxoSmithKline Vol#: 9
98P-0151 Introduction Of Downed Cattle Into The Food Supply
C 6002 Carol Schmidtke Vol#: 263
C 6003 Sandra Deurloo Vol#: 263
C 6004 Mrs. Anne E. Bigler Vol#: 263
C 6005 Sylvia G. Steiner Vol#: 263
C 6006 Mr. Conrad Partheymueller Vol#: 263
C 6007 Mr. & Mrs. Joseph Giomelli Vol#: 263
C 6008 Kathy Glasgow Vol#: 263
C 6009 Marion Fay Vol#: 263
C 6010 Mary Allen Vol#: 263
C 6011 Margo Cusano Vol#: 263
C 6012 Angela G. Weber Vol#: 263
C 6013 Chris Mandell Vol#: 263
C 6014 Virginia D. Austin Vol#: 263
C 6015 Ms. Betty J. Smawley Vol#: 263
C 6016 Leslie S. Vol#: 263
C 6017 D. Slack Vol#: 263
C 6018 Daphne Cripps Vol#: 263
C 6019 Ms. J F Vol#: 263
C 6020 J. V. Romano Vol#: 263
00C-1321 Safe use of mica in contact lenses
NFR 1 Vol#: 1
REF 1 References 1-4 found in 67FR65311 Vol#: 1
01E-0363 Patent Term Extension Application, MIFEPREX No. 4,386,085
LET 10 Corcept Therapeutics, Inc. Vol#: 1
N 2 Vol#: 1
01E-0365 Patent Term Extension Application, NEXIUM 4,738,974
LET 5 Corcept Therapeutics, Inc. Vol#: 1
01P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
C 238 Ruth Wood Vol#: 10
02D-0254 Inhalation Drug Products packaged in Semipermeable container
C 3 Novartis Pharms Corp. Vol#: 1
02N-0012 Postmarketing Adverse Drug Experience Reporting;Agency Infor
NAL 1 Vol#: 1
SS 1 Supporting Statement Vol#: 1
02P-0377 Petition Requesting Stay of Approval of Mifeprex
C 1 Lara Bishop Vol#: 1